Skip to content

Author

Nianping Liu

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 10867: CXCR3 Blockade Uncouples Immunotherapy-Induced Myocarditis from Anti-Tumor Immunity Through Oxygen-Dependent mTORC1/HIF1α Metabolic Adaptation

Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but can cause ICI myocarditis (ICIM), a potentially fatal complication driven by aberrant CD8 + T-cell responses. Current therapies reduce cardiac inflammation but may compromise anti-tumor immunity. We observed that CXCR3 inhibitio...

Yin Sun, M. R. Vitale, Tanvi Shankar et al. · 0 citations
Open access Sep 2026

Bio-Babel: autonomous cross-language reconstruction of agent-ready computational biology ecosystems

Scientific software is often locked in its source language, callable from others but not natively extensible or built upon. We present Bio-Babel (biobabel.stanford.edu), an autonomous framework that rebuilds software natively in target ecosystems and makes it agent-callable, shipping each package with an agent-readable...

Nianping Liu, Xuan-Zhi Chen, Miao Cui et al. · 0 citations
Open access Sep 2026

Kidney fibrosis is mediated by GARP-restricted TGF-β activation in fibroblasts.

GARP-mediated release of active TGF-β is identified as a critical step in sustaining fibroblast activation during kidney fibrosis and highlight GARP as a promising therapeutic target for CKD.

Yin-Tong Chen, Wei-Wei Xu, Jie-Li Yu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.